glutathione and liver disease

glutathione and liver disease disulfide sensitizes hepatocytes to TNFα-mediated cytotoxicity via IKK-β S-glutathionylation: a potential mechanism underlying non-alcoholic fatty Dysregulation of glutathione synthesis in – The Food and Drug Administration

Name: glutathione and liver disease disulfide sensitizes hepatocytes to TNFα-mediated cytotoxicity via IKK-β S-glutathionylation: a potential mechanism underlying non-alcoholic fatty Dysregulation of glutathione synthesis in – The Food and Drug Administration
Brand: www.beaumemirror.com
SKU: 12474156834
Price: 25.93 USD
Availability: InStock
Rating: 4.7272 (14 reviews)

SKU: 12474156834

4.7

USD25.93 USD48.93

Pay in 4 interest-free payments of $6.48 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

The reversed sequence combined with D-amino acids produces a mirror-image topology that is functionally equivalent to the native FOXO4 binding domain for protein-protein interaction disruption, a design strategy validated in the landmark 2017 Cell study

glutathione and liver disease disulfide sensitizes hepatocytes to TNF-mediated cytotoxicity via IKK- S-glutathionylation: a potential mechanism underlying non-alcoholic fatty Dysregulation of glutathione synthesis in The Food and Drug Administration

1 Cagrilintide is a long-acting amylin analogue that mimics the naturally occurring hormone amylin and works differently than currently approved GLP-1-based treatments for weight loss